Debut Plus

₹333.25

▼ -6.77 -1.99%

As of 10 Sept 2026 · delayed

BSE Listed

ESM · ESM 2
What does ESM · ESM 2 mean?
BSE · Enhanced Surveillance Measure (ESM 2)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-07-13

Aptus Pharma Limited (544529)

Volume: 21,600Avg Vol 1W: 11,520Avg Vol 1M: 13,45552W Range:₹32.32₹341.7
BSE www.aptus-pharma.com AI Report
Key Ratios
Checked 4h ago
Market Cap—
Current Price₹333.25
Previous Close₹340.02
High / Low (52w)₹341.7 / ₹32.32
Volume21,600
Avg Vol (1W)11,520
Avg Vol (1M)13,455
Stock P/E—
Book Value—
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B—
Debt / Equity0.58
50 DMA₹275.19
200 DMA₹162.47
Day change-1.99%
SurveillanceESM · ESM 2
Price Chart
₹333.25▲ 881.88% · 1Y
₹340₹3320.9L
2025-09-30
2026-09-10

20-day avg volume: 11K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 90% YoY.
  • Net profit is growing year over year.
Profit & Loss (Annual)
MetricMar 2023Mar 2024Mar 2025Mar 2026
Revenue₹14 Cr₹18 Cr₹25 Cr₹47 Cr
EBITDA₹0 Cr₹1 Cr₹5 Cr₹7 Cr
Net Profit₹0 Cr₹1 Cr₹3 Cr₹5 Cr
EPS1.35.326.377.78
Balance Sheet
MetricMar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹6 Cr₹10 Cr₹22 Cr₹44 Cr
Total Liabilities₹5 Cr₹8 Cr₹15 Cr₹20 Cr
Equity₹1 Cr₹2 Cr₹7 Cr₹23 Cr
Total Debt————
Cash Flow
MetricMar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹-2 Cr₹-1 Cr₹-4 Cr
Investing₹0 Cr₹0 Cr₹-1 Cr₹-6 Cr
Financing₹1 Cr₹3 Cr₹7 Cr₹8 Cr
Free Cash Flow₹0 Cr₹-2 Cr₹-1 Cr₹-4 Cr
Shareholding
Promoter 72.89% Institutions 0% Public 27.11%
Efficiency & Working Capital
ROCE—
Interest Coverage9
Dividend Payout—
Debtor Days147 d
Inventory Days106 d
Payable Days64 d
Cash Conversion Cycle189 d
Working Capital Days253 d
Shareholding Details

As of 2026-06-30

Promoter72.9%
FII0%
DII0%
Institutions0%
Public27.1%
Promoter Pledge0%
No. of Shareholders686
Shareholding Pattern

Quarterly — figures in %. Latest 6 quarters.

PeriodJun 2025Sept 2025Dec 2025Mar 2026May 2026Jun 2026
Promoters72.9%72.9%72.9%72.9%72.9%72.9%
FIIs10%10%0%0%0%0%
DIIs2.8%2.8%0%0%0%0%
Public14.3%14.3%27.1%27.1%27.1%27.1%
Promoter Pledge0%0%0%0%0%0%
No. of Shareholders213213302337356686
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Tejash Maheshchandra HathiShareholding of Promoter and Promoter Group11.4%19,62,500
Kapil Hasmukhbhai ChandaranaShareholding of Promoter and Promoter Group11.4%19,62,500
Riddhish Natwarlal TannaShareholding of Promoter and Promoter Group8.6%14,82,500
Kripaliben Mayank ThakkerShareholding of Promoter and Promoter Group8.6%14,82,500
Milly Chetan LalsetaShareholding of Promoter and Promoter Group8.6%14,82,500
Kunjal Piyushbhai UnadkatShareholding of Promoter and Promoter Group8.6%14,82,500
Gaurang Rameshchandra ThakkerShareholding of Promoter and Promoter Group8.6%14,82,500
Ghanshyam Vinubhai PansuriyaShareholding of Promoter and Promoter Group5.3%9,10,000
Chatrabhuj Vallabhbhai ButaniShareholding of Promoter and Promoter Group1.5%2,52,500
Board of Directors
NameDesignationYear
Tejash Maheshchandra HathiManaging Director2025
CHETAN SHANTILAL LALSETANon Executive Director2025
Jyotiben Hasmukhbhai ChandaranaNon Executive Director2025
Riddhish Natwarlal TannaNon Executive Director2025
Vikas Rambhai JobanputraIndependent Director2025
Sejal Harit PalanIndependent Director2025
Mohini Hardikbhai GandhiCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10777
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-17Board Meetings—
forthcoming2026-08-08Board Meetings—
bonus2026-05-12Bonus issue 3:2—
bonus2026-05-123:23:2 Bonus Issue of Equity Shares
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000012
2025000000
2025000011
Insider / Designated-Person Trades

9 recent disclosure(s)

Chatrabhujbhai ButaniDisposal · 1,24,000
TEJASH MAHESHCHANDRA HATHIAcquisition · 10,000
Riddhish Natwarlal TannaAcquisition · 18,000
Milly Chetan LalsetaAcquisition · 18,000
Kunjal Piyushbhai UnadkatAcquisition · 18,000
Kripaliben Mayank ThakkerAcquisition · 18,000
Substantial Acquisitions (SAST)

9 disclosure(s)

Off Market11/05/2026 · 10,000
Off Market / Inter se transfer11/05/2026 · 18,000
Off Market / Inter se transfer11/05/2026 · 18,000
Off Market / Inter se transfer11/05/2026 · 18,000
Off Market / Inter se transfer11/05/2026 · 18,000
Off Market11/05/2026 · 10,000
Company Information
Incorporated2010
AuditorA B K B & Co
Investor Email[email protected]
🌐 www.aptus-pharma.com ↗

📍 Ashutosh Buildcon Asali, Daskroi, Ahmedabad, Gujarat, 382427

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Sampat Aluminium LimitedIvalue InfosolutionsJD Cables LimitedSaatvik Green EnergyAtlanta ElectricalsGanesh Consumer ProductsAnand Rathi Share & Stock BrokersTrue Colors LimitedSolarworld Energy SolutionsSeshaasai TechnologiesJaro Inst of Tech Mgmt & ResearchBharatRohan Airborne Innovations Ltd.All “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search